-
www.ahrq.gov/healthsystemsresearch/hspc-research-study/breadth-and-focus.html
July 01, 2021 - 3. Breadth and Focus Areas of Federal Agency Research Portfolios in HSR and PCR
Health Services and Primary Care Research Study: Comprehensive Report
This chapter addresses the study’s first key question: What is the breadth and focus of federally funded HSR and PCR? There are two main components to this chap…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - Opioid medications
are also used for selected patients with
refractory, chronic pain but are not
recommended
-
hcup-us.ahrq.gov/reports/natstats/his95/appendc.pdf
February 11, 2011 - 2912 2913 2914 2915
2918 29181 29189 2919
5.2.2 Substance-related mental disorders 67 -
5.2.2.1 Opioid
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary24/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
March 11, 2014 - years reported using a prescription drug for nonmedical reasons, and 2.2% reported nonmedical use of opioid
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/problem-drinking-screening-1996
January 01, 1996 - Two short-term (12 weeks) randomized trials demonstrated a significant benefit of naltrexone, an opioid
-
effectivehealthcare.ahrq.gov/health-topics/heroin
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/final-rapid-cycle-research-guidance.pdf
June 01, 2015 - considerations for point-of-care
clinical trials comparing methadone and buprenorphine treatment for opioid … considerations for point-of-care clinical
trials comparing methadone and buprenorphine
treatment for opioid … This article describes the study design for a point-
of-care RCT to treat pregnant women with opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
July 01, 2022 - patients with acute exacerbations of
chronic pain, pregnant/breastfeeding women, and patients with opioid … Effectiveness and safety of non-steroidal
anti-inflammatory drugs and opioid
treatment for knee and
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Triggers associated with opioid and
benzodiazepine toxicity, intravenous
infiltration, hypoglycemia
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diverticulitis-research-protocol.pdf
January 01, 2019 - diverticulitis-related and all-cause
• Medium- to long term (>1 month)
o Recurrent diverticulitis
o Opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - drugs Androgens-anabolic Nutritional products Multivitamins
Analgesics and anesthetics Analgesics - opioid
-
hcup-us.ahrq.gov/reports/SOI.jsp
June 01, 2016 - Drug abuse, dependence, intoxication: Hallucinogen (10)
Drug abuse, dependence, intoxication: Opioid
-
hcup-us.ahrq.gov/reports/ED_MHSA_SOIpaper.pdf
June 10, 2011 - 12)
Drug abuse, dependence, intoxication: Hallucinogen (10)
Drug abuse, dependence, intoxication: Opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-pregnant-protocol.pdf
August 24, 2023 - outcomes, such as preterm birth, low birth weight, operative deliveries, poorer postpartum pain
control, opioid
-
www.ahrq.gov/patient-safety/reports/candor-demo-program/plan-grants/appa.html
August 01, 2022 - Planning Grants Final Evaluation Report
Appendix A. Grantee Profiles
Previous Page Next Page
Table of Contents
Planning Grants Final Evaluation Report
Executive Summary
Introduction
Methodology
Findings
Appendix A. Grantee Profiles
Appendix B. References
Carilion Medical …
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE.pdf
January 01, 2023 - substance use disorder who
completed treatment course
TEDSD 2020
Hospital inpatient stays involving opioid-related … diagnoses per
100,000 population
HCUP 2020
Emergency department visits involving opioid-related … Disparities Report
2023 National Healthcare Quality and Disparities Report E-5
• MOUD: medication for opioid
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE-rev.pdf
January 01, 2023 - substance use disorder who
completed treatment course
TEDSD 2020
Hospital inpatient stays involving opioid-related … diagnoses per
100,000 population
HCUP 2020
Emergency department visits involving opioid-related … Disparities Report
2023 National Healthcare Quality and Disparities Report E-5
• MOUD: medication for opioid
-
digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
October 01, 2011 - Enhanced Medication Histories
Enhanced Medication
Histories
Final ACTION Contract Report
Final Report
Enhanced Medication Histories
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - There have been 2 landmark papers published regarding novel studies using low dose
naltrexone, an opioid … Smith, MD
Introduction Naltrexone is an opioid receptor antagonist that was shown in an animal model
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024587-schnipper-final-report-2019.pdf
January 01, 2019 - Electronic Medication Adherence Reporting and Feedback During Care Transitions - Final Report
Electronic Medication Adherence Reporting and Feedback During Care Transitions
Principal Investigator: Jeffrey L. Schnipper, MD, MPH
Team Members: Harry Reyes Nieva, MAS; Amrita Chabria, PharmD; Katie Czado, PharmD; Eva…